As a young company, any stream of revenue is great. It's all a way to help fund research on our own market products.

We are really a company in transition from research and development to product development. I think we're at the point of rapid growth; I think we're right on the edge of that.

We are excited to be a part of such an esteemed group of business leaders. As a cutting-edge company embarking on North American expansion, we want to exchange ideas and continue innovating the market space.

The Stem Cell Research Enhancement Act would expand research on embryonic stem cells by increasing the number of lines stem cells that would be eligible for federally funded research.

The research is that the more you fiddle with your portfolio the worse you do. Investors rarely benefit from fiddling with their portfolio. My only advice to people that tweak their portfolios is to stop.

Ford would welcome the cash for liquidity purposes, to help provide for large unfunded pension liabilities and for research and development,